106 related articles for article (PubMed ID: 28181134)
1. The effect and mechanism of dopamine D1 receptors on the proliferation of osteosarcoma cells.
Gao J; Zhang C; Gao F; Li H
Mol Cell Biochem; 2017 Jun; 430(1-2):31-36. PubMed ID: 28181134
[TBL] [Abstract][Full Text] [Related]
2. Dopamine D1 receptors induce apoptosis of osteosarcoma cells via changes of MAPK pathway.
Gao J; Gao F
Clin Exp Pharmacol Physiol; 2017 Nov; 44(11):1166-1168. PubMed ID: 28699280
[TBL] [Abstract][Full Text] [Related]
3. Dopamine D1-Like Receptors Suppress the Proliferation of Macrophages Induced by Ox-LDL.
Yao Y; Yang D; Han Y; Wang W; Wang N; Yang J; Zeng C
Cell Physiol Biochem; 2016; 38(1):415-26. PubMed ID: 26824460
[TBL] [Abstract][Full Text] [Related]
4. Calcium-sensing receptor activating ERK1/2 and PI3K-Akt pathways to induce the proliferation of osteosarcoma cells.
Zhao W; Zhang Z; Zheng L; You C; Chi H; Zhang T; Xu G
Clin Exp Pharmacol Physiol; 2020 Mar; 47(3):517-519. PubMed ID: 31705676
[TBL] [Abstract][Full Text] [Related]
5. Synergistic interactions of dopamine D1 and glutamate NMDA receptors in rat hippocampus and prefrontal cortex: involvement of ERK1/2 signaling.
Sarantis K; Matsokis N; Angelatou F
Neuroscience; 2009 Nov; 163(4):1135-45. PubMed ID: 19647050
[TBL] [Abstract][Full Text] [Related]
6. The DR1‑CSE/H
Li H; Sun F; Bai S; Chang G; Wu R; Wei Y; Wen X; Xi Y; Hao J; Zaid A
Int J Mol Med; 2022 Jan; 49(1):. PubMed ID: 34779492
[TBL] [Abstract][Full Text] [Related]
7. Down-Regulation of Ubiquitin-Specific Peptidase 9X Inhibited Proliferation, Migration and Invasion of Osteosarcoma via ERK1/2 and PI3K/Akt Signaling Pathways.
Zheng W; Li S; Huang J; Dong Y; Zhang H; Zheng J
Biol Pharm Bull; 2022; 45(9):1283-1290. PubMed ID: 36047196
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor-2 and -4 promote the proliferation of bone marrow mesenchymal stem cells by the activation of the PI3K-Akt and ERK1/2 signaling pathways.
Choi SC; Kim SJ; Choi JH; Park CY; Shim WJ; Lim DS
Stem Cells Dev; 2008 Aug; 17(4):725-36. PubMed ID: 18788932
[TBL] [Abstract][Full Text] [Related]
9. Elevated expression of CTRP3/cartducin contributes to promotion of osteosarcoma cell proliferation.
Akiyama H; Furukawa S; Wakisaka S; Maeda T
Oncol Rep; 2009 Jun; 21(6):1477-81. PubMed ID: 19424626
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-196a overexpression promotes cell proliferation and inhibits cell apoptosis through PTEN/Akt/FOXO1 pathway.
Shang Y; Wang LQ; Guo QY; Shi TL
Int J Clin Exp Pathol; 2015; 8(3):2461-72. PubMed ID: 26045752
[TBL] [Abstract][Full Text] [Related]
11. D1 dopamine receptor mediates dopamine-induced cytotoxicity via the ERK signal cascade.
Chen J; Rusnak M; Luedtke RR; Sidhu A
J Biol Chem; 2004 Sep; 279(38):39317-30. PubMed ID: 15247297
[TBL] [Abstract][Full Text] [Related]
12. Changes in apical dendritic structure correlate with sustained ERK1/2 phosphorylation in medial prefrontal cortex of a rat model of dopamine D1 receptor agonist sensitization.
Papadeas ST; Halloran C; McCown TJ; Breese GR; Blake BL
J Comp Neurol; 2008 Nov; 511(2):271-85. PubMed ID: 18785628
[TBL] [Abstract][Full Text] [Related]
13. Dopamine 1 receptors inhibit apoptosis via activating CSE/H
Li H; Wu R; Xi Y; Li H; Chang G; Sun F; Wei C; Jiao L; Wen X; Zhang G; Zaid A; Hao J
Cell Biol Int; 2022 Jul; 46(7):1098-1108. PubMed ID: 35293655
[TBL] [Abstract][Full Text] [Related]
14. Sleep during acute dopamine D1 agonist SKF 38393 or D1 antagonist SCH 23390 administration in rats.
Monti JM; Fernández M; Jantos H
Neuropsychopharmacology; 1990 Jun; 3(3):153-62. PubMed ID: 2141985
[TBL] [Abstract][Full Text] [Related]
15. Agonist efficacy and the behavioral effects of dopamine D1 receptor ligands: drug interaction studies in squirrel monkeys.
Bergman J; Spealman RD; Madras BK; Rosenzweig-Lipson S
J Pharmacol Exp Ther; 1996 Mar; 276(3):942-50. PubMed ID: 8786574
[TBL] [Abstract][Full Text] [Related]
16. Prevention of tumour cell apoptosis associated with sustained protein kinase B phosphorylation is more sensitive to regulation by insulin signalling than stimulation of proliferation and extracellular signal-regulated kinase.
Schmid C; Ghirlanda C; Niessen M
Mol Cell Biochem; 2017 Aug; 432(1-2):41-54. PubMed ID: 28316059
[TBL] [Abstract][Full Text] [Related]
17. The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats.
Wirtshafter D; Osborn CV
Eur J Pharmacol; 2005 Dec; 528(1-3):88-94. PubMed ID: 16324697
[TBL] [Abstract][Full Text] [Related]
18. RNAi-mediated knockdown of ERK1/2 inhibits cell proliferation and invasion and increases chemosensitivity to cisplatin in human osteosarcoma U2-OS cells in vitro.
Si H; Peng C; Li J; Wang X; Zhai L; Li X; Li J
Int J Oncol; 2012 Apr; 40(4):1291-7. PubMed ID: 22179790
[TBL] [Abstract][Full Text] [Related]
19. MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathway.
Dong Y; Liang G; Yuan B; Yang C; Gao R; Zhou X
Tumour Biol; 2015 Mar; 36(3):1477-86. PubMed ID: 25431257
[TBL] [Abstract][Full Text] [Related]
20. [Combined inhibition of PI3K and MEK has synergistic inhibitory effect on the proliferation of cisplatin-resistant ovarian cancer cells].
Liu Y; Chen X; Luo Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):592-6. PubMed ID: 24909280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
